Beam Therapeutics (BEAM) FCF Margin (QoQ) (2019 - 2026)
Beam Therapeutics (BEAM) FCF Margin (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Beam Therapeutics | 2.68 Bn | 2.68 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34,059.00 |
| Dec 31, 2025 | 73,709.00 |
| Sep 30, 2025 | 13,161.00 |
| Jun 30, 2025 | 49,165.00 |
| Mar 31, 2025 | -117,646.00 |
| Dec 31, 2024 | 33,467.00 |
| Sep 30, 2024 | 13,187.00 |
| Jun 30, 2024 | 65,722.00 |
| Mar 31, 2024 | -143,082.00 |
| Dec 31, 2023 | 62,025.00 |
| Sep 30, 2023 | -6,711.00 |
| Jun 30, 2023 | -2,284.00 |
| Mar 31, 2023 | -9,194.00 |
| Dec 31, 2022 | 28,630.00 |
| Sep 30, 2022 | -39,749.00 |
| Jun 30, 2022 | -268,504.00 |
| Mar 31, 2022 | 243,227.00 |
| Dec 31, 2021 | 34,084.00 |
| Sep 30, 2021 | 99.97 Mn |
| Jun 30, 2021 | -35.40 Mn |